A novel oral indoline-sulfonamide agent; J30; exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.

劉景平Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY;2026-05-212026-05-212007https://203.71.86.71/handle/123456789/23501en-US藥學系期刊論文A novel oral indoline-sulfonamide agent; J30; exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.article